---
title: 'Research Daily Summary: What Happened on October 16, 2026'
headline: Transcripta Bio and Mayo Clinic team up on ALS drug discovery
description: The collaboration will pair patient tissue and clinical information with
Transcripta’s molecular profiling platform to search for disease targets.
url: https://thebench.bio/news/research/2026-10-16
topic: research
date: '2026-10-16'
covers:
- '2026-10-16'
date_published: '2026-10-16T12:03:50Z'
date_modified: '2026-10-16T12:03:50Z'
tags:
- Industry
sources: 1
publisher: TheBench.Bio
---
# Research Daily Summary: What Happened on October 16, 2026
**Transcripta Bio and Mayo Clinic team up on ALS drug discovery**
The collaboration will pair patient tissue and clinical information with Transcripta’s molecular profiling platform to search for disease targets.
## Today in brief
Transcripta Bio and Mayo Clinic entered a research and licensing collaboration to study ALS and identify potential treatments and therapeutic targets. [1]
## Mapping ALS biology
Mayo Clinic is recruiting living patients with sporadic and familial ALS under an Institutional Review Board-approved protocol. [1] Transcripta plans to use its transcriptomic drug-discovery platform to profile patient tissue and compare those profiles with existing drug-response data, seeking possible targets and drug candidates. [1]
The project aims to map differences in ALS biology among patients and across disease progression, with findings that could support care and targeted drug development. [1]
## Also published
- [Temperature and air pollution associated with increased risk of type 2 diabetes](), Clinical Trials Arena
- [Festival of Science & Curiosity: a day full of science, curiosity, and connection](), EMBL
## Sources
1. [Transcripta Bio, Mayo Clinic join force on ALS therapies](), Pharmaceutical Technology, 2026-10-16
---
TheBench.Bio wrote this from the reporting cited above, with a language model drafting and editing.
[1]: